कृपया अन्य खोज का प्रयास करें
Kolon TissueGene, Inc. engages in developing cell therapies to target various orthopedic diseases and degenerative disorders. The company develops cell therapies for osteoarthritis, including knee and hip; musculoskeletal system disorder comprising spinal disk; and vet medicine for knee. It also has collaboration with Kolon Life Science, Inc. The company was formerly known as TissueGene, Inc. and changed its name to Kolon TissueGene, Inc. in March 2018. Kolon TissueGene, Inc. was founded in 1999 and is based in Rockville, Maryland.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
David Hunter | - | 2016 | Member of Scientific Advisory Board |
Philip G. Conaghan | - | 2017 | Member of Scientific Advisory Board |
Peter Shin | - | - | Member of Business Advisory Board |
Javad Parvizi | - | - | Member of Clinical Advisory Board |
Michael A. Mont | - | - | Member of Clinical Advisory Board |
Jung In Kim | - | 2021 | CFO & Director |
Terry L. Lierman | 74 | - | Member of Business Advisory Board |
Moon-jong Noh | - | 2001 | Co-CEO, Co-President & Director |
Sung Han | - | 2020 | Co-CEO, Co-President & Director |
Ali Mobasheri | - | 2020 | Member of the Scientific Advisory Board |
SunJoo Lee | - | 2023 | Independent Outside Director |
Young J. Kim | - | 2021 | Statutory Auditor & Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है